Cargando…

The Impact of Aberrant Data Variability on Drug–Placebo Separation and Drug/Placebo Response in an Acute Schizophrenia Clinical Trial

OBJECTIVE: In the current posthoc analyses, we evaluated the impact of markers of aberrant data variability on drug placebo separation and placebo and drug response in an acute schizophrenia clinical trial. METHODS: Positive and negative syndrome scale data were obtained from a phase 2, randomized,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kott, Alan, Brannan, Stephen, Wang, Xingmei, Daniel, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650072/ https://www.ncbi.nlm.nih.gov/pubmed/34901869 http://dx.doi.org/10.1093/schizbullopen/sgab037

Ejemplares similares

What Is Causing the Reduced Drug-Placebo Difference in Recent Schizophrenia Clinical Trials and What Can be Done About It?
por: Kemp, Aaron S., et al.
Publicado: (2010)

Placebo Response in Trials of Negative Symptoms in Schizophrenia: A Critical Reassessment of the Evidence
por: Czobor, Pál, et al.
Publicado: (2022)

Antidepressive Effect of Antipsychotics in the Treatment of Schizophrenia: Meta-Regression Analysis of Randomized Placebo-Controlled Trials
por: Miura, Itaru, et al.
Publicado: (2020)

Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial
por: Sommer, Iris E, et al.
Publicado: (2021)

Efficacy and safety of lurasidone in acutely psychotic patients with schizophrenia: A 6‐week, randomized, double‐blind, placebo‐controlled study
por: Iyo, Masaomi, et al.
Publicado: (2021)

N-Acetylcysteine (NAC) in Schizophrenia Resistant to Clozapine: A Double-Blind, Randomized, Placebo-Controlled Trial Targeting Negative Symptoms
por: Neill, Erica, et al.
Publicado: (2022)

Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial
por: Samaei, Areoo, et al.
Publicado: (2020)

Drug*placebo interaction effect may bias clinical trials interpretation: hybrid balanced placebo and randomized placebo-controlled design
por: Hammami, Muhammad M., et al.
Publicado: (2016)

Interaction between drug and placebo effects: a cross-over balanced placebo design trial
por: Hammami, Muhammad M, et al.
Publicado: (2010)

Drugs and Placebos: What’s the Difference?
por: Benedetti, Fabrizio
Publicado: (2022)

Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response
por: Jarcho, Johanna M., et al.
Publicado: (2015)

Placebo response in binge eating disorder
por: Jacobs-Pilipski, M Joy, et al.
Publicado: (2007)

S246. THE EFFECT OF INCORRECT SCALE ADMINISTRATION ON DATA QUALITY IN SCHIZOPHRENIA CLINICAL TRIALS
por: Kott, Alan, et al.
Publicado: (2020)

Ethical and Scientific Perspectives of Placebo-controlled Trials in Schizophrenia
por: Melamed, Yuval, et al.
Publicado: (2009)

Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer
por: Langman, M J S, et al.
Publicado: (1999)

Safety and tolerability of KarXT (xanomeline–trospium) in a phase 2, randomized, double-blind, placebo-controlled study in patients with schizophrenia
por: Correll, Christoph U., et al.
Publicado: (2022)

Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?
por: Keefe, Richard S. E., et al.
Publicado: (2013)

Schizophrenia is Associated With an Aberrant Immune Response to Epstein–Barr Virus
por: Dickerson, Faith, et al.
Publicado: (2019)

Evaluation of the Efficacy, Safety, and Tolerability of BI 409306, a Novel Phosphodiesterase 9 Inhibitor, in Cognitive Impairment in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
por: Brown, David, et al.
Publicado: (2019)

Aberrant effective connectivity is associated with positive symptoms in first-episode schizophrenia
por: Dietz, Martin J., et al.
Publicado: (2020)

Measuring brain glucose metabolism in order to predict response to antidepressant or placebo: A randomized clinical trial
por: Hill, Kathryn R., et al.
Publicado: (2021)

Interaction between expectancies and drug effects: an experimental investigation of placebo analgesia with caffeine as an active placebo
por: Bjørkedal, Espen, et al.
Publicado: (2011)

Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study
por: Fleischhacker, W. Wolfgang, et al.
Publicado: (2016)

Attitudes toward Placebo-Controlled Clinical Trials of Patients with Schizophrenia in Japan
por: Sugawara, Norio, et al.
Publicado: (2015)

Randomised Controlled Trials May Underestimate Drug Effects: Balanced Placebo Trial Design
por: Lund, Karen, et al.
Publicado: (2014)

Suppression of Helicobacter pylori infection by daily cranberry intake: A double‐blind, randomized, placebo‐controlled trial
por: Li, Zhe‐Xuan, et al.
Publicado: (2020)

Factors Influencing the Cardiovascular Response to Subanesthetic Ketamine: A Randomized, Placebo-Controlled Trial
por: Liebe, Thomas, et al.
Publicado: (2017)

Aberrant prefrontal beta oscillations predict episodic memory encoding deficits in schizophrenia
por: Meconi, Federica, et al.
Publicado: (2016)

A triple-blinded, randomized, placebo-controlled trial to examine the efficacy of buspirone added to typical antipsychotic drugs in patients with chronic schizophrenia
por: Sheikhmoonesi, Fatemeh, et al.
Publicado: (2015)

A meta-analysis of the placebo response in antimuscarinic drug trials for overactive bladder
por: Lee, Soyon, et al.
Publicado: (2009)

Homeopathic drug proving of Okoubaka aubrevillei: a randomised placebo-controlled trial
por: Teut, Michael, et al.
Publicado: (2013)

Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study
por: Sauder, Colin, et al.
Publicado: (2022)

Efficacy and Safety of Low-Dose Brexpiprazole for Acute Schizophrenia: Meta-Analysis of Randomized Placebo-Controlled Trials
por: Zhao, Mingjun, et al.
Publicado: (2022)

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis
por: Conus, Philippe, et al.
Publicado: (2018)

P.508 COVID-19 impact on entry symptom severity in schizophrenia clinical trials – preliminary data
por: Kott, A., et al.
Publicado: (2020)

Aberrant patterns of neural activity when perceiving emotion from biological motion in schizophrenia
por: Jimenez, Amy M., et al.
Publicado: (2018)

Aberrant activity in conceptual networks underlies N400 deficits and unusual thoughts in schizophrenia
por: Jacob, Michael S., et al.
Publicado: (2019)

A randomised, double-blind, placebo-controlled trial of tropisetron in patients with schizophrenia
por: Shiina, Akihiro, et al.
Publicado: (2010)

Randomized, Placebo-Controlled Clinical Trial of Omega-3 as Supplemental Treatment in Schizophrenia
por: Jamilian, Hamidreza, et al.
Publicado: (2014)

Randomised Double-Blind Comparison of Placebo and Active Drugs for Effects on Risks Associated with Blood Pressure Variability in the Systolic Hypertension in Europe Trial
por: Hara, Azusa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hdpc9478vuipeg57vn99bhnfj6